Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps: An analysis of randomized clinical trials

ConclusionOmalizumab improved sleep and self-reported health status in patients with CRSwNP. This contributes to evidence that omalizumab provides value for patients beyond the reduction of sinonasal symptoms.

Source: International Forum of Allergy and Rhinology - January 11, 2024 Category: Allergy & Immunology Authors: Eli O. Meltzer, Joaquim Mullol, Jinnie Ko, Rebecca Saenz, John W. Steinke, Lauren A. Millette, Philippe Gevaert Tags: ORIGINAL ARTICLE Source Type: research